U.S. Topical Pain Relief Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global U.S. Topical Pain Relief market garnered revenue around USD 4,713 million in 2020 and projected to reach USD 5,373 million in 2027, with at a compound annual growth rate (CAGR) 5.8% throughout the estimate period from 2021 to 2027. Topical pain relief medications are applied directly to the epidermal layer of the skin at the area of inflammation or pain. Topical pain relief products are designed to relieve pain and utilize skin as the vehicle for drug administration and exert major action at the targeted site & in the central nervous system. These formulations are analgesic or anesthetic agents which are applied on or around the painful site. The aim is to offer a slow and gradual release of pain relief medication into the bloodstream by keeping the blood levels relatively constant for a certain period of time. These medications offer lesser side effects as compared to oral medications. Topical pain relievers include the administration of non-opioids and opioids drugs. Non-opioids drugs include nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylates, capsaicin, lidocaine, and other non-opioids. Opioids drugs include buprenorphine and fentanyl.  

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the U.S. Topical Pain Relief market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the U.S. Topical Pain Relief market growth.

The global U.S. Topical Pain Relief market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The key players profiled in this report include Advacare Pharma, Glaxosmithkline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd., and Topical Biomedics, Inc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Therapeutic Class

·         Non-opioids

·         Nonsteroidal anti-inflammatory drug (NSAIDS)

·         Methyl Salicylate

·         Capsaicin

·         Lidocaine

·         Other Non-opioids

·         Opioids

·         Buprenorphine

·         Fentanyl

By Formulation

·         Cream

·         Gel

·         Spray

·         Patch

·         Others

By Type

·         Prescription Pain Relief

·         Over-the-counter (OTC) Pain Relief

By Distribution Channel

·         Pharmacy & Drug Store

·         e-Commerce

·         Retail & Grocery Store

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

 

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global U.S. Topical Pain Relief Market, By Therapeutic Class

7.1.  U.S. Topical Pain Relief Market, By Therapeutic Class, 2021-2027

7.1.1.    Non-opioids

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Nonsteroidal anti-inflammatory drug (NSAIDS)

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Methyl Salicylate

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Capsaicin

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    Lidocaine

7.1.5.1.        Market Revenue and Forecast (2016-2027)

7.1.6.    Other Non-opioids

7.1.6.1.        Market Revenue and Forecast (2016-2027)

7.1.7.    Opioids

7.1.7.1.        Market Revenue and Forecast (2016-2027)

7.1.8.    Buprenorphine

7.1.8.1.        Market Revenue and Forecast (2016-2027)

7.1.9.    Fentanyl

7.1.9.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global U.S. Topical Pain Relief Market, By Formulation

8.1.  U.S. Topical Pain Relief Market, By Formulation, 2021-2027

8.1.1.    Cream

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Gel

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Spray

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Patch

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Others

8.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global U.S. Topical Pain Relief Market, By Type

9.1.  U.S. Topical Pain Relief Market, By Type, 2021-2027

9.1.1.    Prescription Pain Relief

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Over-the-counter (OTC) Pain Relief

9.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global U.S. Topical Pain Relief Market, By Distribution Channel

10.1.        U.S. Topical Pain Relief Market, By Distribution Channel, 2021-2027

10.1.1.  Pharmacy & Drug Store

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  e-Commerce

10.1.2.1.      Market Revenue and Forecast (2016-2027)

10.1.3.  Retail & Grocery Store

10.1.3.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global U.S. Topical Pain Relief  Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Vehicle (2016-2027)

11.1.2.  Market Revenue and Forecast, by Coating (2016-2027)

11.1.3.  Market Revenue and Forecast, by Technology (2016-2027)

11.1.4.  Market Revenue and Forecast, by Texture (2016-2027)

11.1.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.1.6.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.1.7.  U.S.

11.1.7.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.1.7.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.1.7.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.1.7.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.1.8.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.1.8.1.      Market Revenue and Forecast, by Raw Material (2016-2027)

11.1.9.  Rest of North America

11.1.9.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.1.9.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.1.9.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.1.9.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.1.10.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.1.11.               Market Revenue and Forecast, by Raw Material (2016-2027)

11.1.11.1.    

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Vehicle (2016-2027)

11.2.2.  Market Revenue and Forecast, by Coating (2016-2027)

11.2.3.  Market Revenue and Forecast, by Technology (2016-2027)

11.2.4.  Market Revenue and Forecast, by Texture (2016-2027)

11.2.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.2.6.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.2.7.   

11.2.8.  UK

11.2.8.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.2.8.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.2.8.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.2.9.  Market Revenue and Forecast, by Texture (2016-2027)

11.2.10.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.2.10.1.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.2.11.               Germany

11.2.11.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.2.11.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.2.11.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.2.12.               Market Revenue and Forecast, by Texture (2016-2027)

11.2.13.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.2.14.               Market Revenue and Forecast, by Raw Material (2016-2027)

11.2.14.1.    

11.2.15.               France

11.2.15.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.2.15.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.2.15.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.2.15.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.2.16.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.2.16.1.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.2.17.               Rest of Europe

11.2.17.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.2.17.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.2.17.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.2.17.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.2.18.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.2.18.1.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Vehicle (2016-2027)

11.3.2.  Market Revenue and Forecast, by Coating (2016-2027)

11.3.3.  Market Revenue and Forecast, by Technology (2016-2027)

11.3.4.  Market Revenue and Forecast, by Texture (2016-2027)

11.3.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.3.6.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.3.7.  India

11.3.7.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.3.7.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.3.7.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.3.7.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.3.8.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.3.9.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.3.10.               China

11.3.10.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.3.10.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.3.10.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.3.10.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.3.11.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.3.11.1.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.3.12.               Japan

11.3.12.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.3.12.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.3.12.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.3.12.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.3.12.5.   Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.3.12.6.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.3.13.               Rest of APAC

11.3.13.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.3.13.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.3.13.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.3.13.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.3.13.5.   Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.3.13.6.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Vehicle (2016-2027)

11.4.2.  Market Revenue and Forecast, by Coating (2016-2027)

11.4.3.  Market Revenue and Forecast, by Technology (2016-2027)

11.4.4.  Market Revenue and Forecast, by Texture (2016-2027)

11.4.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.4.6.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.4.7.  GCC

11.4.7.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.4.7.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.4.7.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.4.7.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.4.8.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.4.9.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.4.10.               North Africa

11.4.10.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.4.10.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.4.10.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.4.10.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.4.11.               Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.4.12.               Market Revenue and Forecast, by Raw Material (2016-2027)

11.4.13.               South Africa

11.4.13.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.4.13.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.4.13.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.4.13.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.4.13.5.   Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.4.13.6.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.4.14.               Rest of MEA

11.4.14.1.   Market Revenue and Forecast, by Vehicle (2016-2027)

11.4.14.2.   Market Revenue and Forecast, by Coating (2016-2027)

11.4.14.3.   Market Revenue and Forecast, by Technology (2016-2027)

11.4.14.4.   Market Revenue and Forecast, by Texture (2016-2027)

11.4.14.5.   Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.4.14.6.   Market Revenue and Forecast, by Raw Material (2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Vehicle (2016-2027)

11.5.2.  Market Revenue and Forecast, by Coating (2016-2027)

11.5.3.  Market Revenue and Forecast, by Technology (2016-2027)

11.5.4.  Market Revenue and Forecast, by Texture (2016-2027)

11.5.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.5.6.  Market Revenue and Forecast, by Raw Material (2016-2027)

11.5.7.  Brazil

11.5.7.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.5.7.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.5.7.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.5.7.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.5.8.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.5.8.1.      Market Revenue and Forecast, by Raw Material (2016-2027)

11.5.9.  Rest of LATAM

11.5.9.1.      Market Revenue and Forecast, by Vehicle (2016-2027)

11.5.9.2.      Market Revenue and Forecast, by Coating (2016-2027)

11.5.9.3.      Market Revenue and Forecast, by Technology (2016-2027)

11.5.9.4.      Market Revenue and Forecast, by Texture (2016-2027)

11.5.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

11.5.9.6.      Market Revenue and Forecast, by Raw Material (2016-2027)

Chapter 12.  Company Profiles

12.1.              Advacare Pharma

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Glaxosmithkline Plc (GSK)

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Johnson & Johnson

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Nestlé S.A.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Novartis AG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Pfizer Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Reckitt Benckiser Group Plc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Sanofi

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Sun Pharmaceutical Industries Ltd.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Topical Biomedics, Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample